types of glp 1 A schematic overview GLP-1 receptor agonists: classification, drug This review summarizes how GLP-1

10.7554/eLife.50208 7 FengY.SuL.ZhongX.GuohongW.XiaoH.LiY.et al (2016)

Pre-treatment: Measure morning resting heart rate for 5 days Calculate average baseline Record any existing caffeine or stimulant use During treatment: Measure resting heart rate 3 times weekly during dose escalation Continue at each dose for minimum 4 weeks before increasing If resting HR exceeds baseline by more than 15 BPM, hold dose for an additional 2 weeks If resting HR exceeds 100 BPM at rest on two or more measurements, consult physician Expected timeline: Weeks 1-8: minimal heart rate change at starting doses Weeks 8-24: gradual increase of 5-10 BPM at therapeutic doses Weeks 24+: stabilization and gradual decline toward baseline This is the approach most researchers follow successfully, and it aligns with the standard retatrutide dosing protocol used in clinical trials

Among these, 6% are currently using such a drug

doi: 10.1016/j.tice.2015.12.003 163 GebremedhnSSalilew-WondimDHoelkerMRingsFNeuhoffCTholenEet al